Multi-Arm GlioblastoMa Australasia (MAGMA): protocol for a multiarm randomised clinical trial for people affected by glioblastoma

INTRODUCTION: Glioblastoma (GBM) is the most common malignant primary central nervous system cancer in adults. The objective of the Multi-Arm GlioblastoMa Australasia (MAGMA) trial is to test hypotheses in real world setting to improve survival of people with GBM. Initial experimental arms are evalu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Benjamin Y, Sim, Hao-Wen, Barnes, Elizabeth H, Nowak, Anna K, Hovey, Elizabeth J, Jeffree, Rosalind, Harrup, Rosemary, Parkinson, Jonathon, Gan, Hui K, Pinkham, Mark B, Yip, Sonia, Hall, Merryn, Tu, Emily, Carter, Candace, Koh, Eng-Siew, Lwin, Zarnie, Dowling, Anthony, Simes, John S, Gedye, Craig
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441685/
https://www.ncbi.nlm.nih.gov/pubmed/36104135
http://dx.doi.org/10.1136/bmjopen-2021-058107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441685/
https://www.ncbi.nlm.nih.gov/pubmed/36104135
http://dx.doi.org/10.1136/bmjopen-2021-058107

Ejemplares similares